Target Market Potential sales opportunities in vascular and interventional devices, focusing on hospital systems and clinics treating peripheral artery disease and vascular diseases where site-specific, non-systemic therapeutic delivery can complement existing procedures.

Strategic Partnerships Leverage past and ongoing collaborations, such as with Salubris and NIH-funded STTR grants, to co-develop and commercialize novel therapeutics, offering joint value propositions to large hospital networks and regional distributors.

Clinical Advancement Capitalize on clinical program milestones like LIMBO-ATX and other vascular trials to position the technology as enabling non-systemic delivery, targeting academic medical centers and research networks seeking innovative treatment modalities.

Funding Readiness Highlight the company’s history of NIH funding and venture backing to engage customers on potential funded opportunities, expansion of trials, and access to government or grant-supported procurement programs.

Competitive Positioning Differentiate from large medical device competitors by emphasizing catheter-guided microfluid delivery as a site-specific, non-systemic approach with potential for new therapeutics in cardiovascular, oncology, and regenerative medicine markets.